Actively Recruiting
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy for Maintenance Hemodialysis Patients
Led by Yunfeng Xia · Updated on 2025-12-18
392
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating whether using the "Yueya" mini-program and WeChat to manage care can improve the quality of blood purification therapy and outcomes for patients undergoing maintenance hemodialysis (MHD). Many MHD patients face negative outlooks due to their illnesses and complications, which can affect their quality of life and prognosis. This trial aims to see if personalized guidance via an app can help improve treatment compliance, quality of life, and patient prognosis. Participants will be randomly assigned to either an APP management group or a non-APP management group. The APP group will receive individualized, continuous support through the "Yueya" mini-program and WeChat, including health education, diet and exercise guidance, medication supervision, condition monitoring, and real-time feedback tailored to their age, gender, primary disease, and complications. The control group will receive routine care without the app-based guidance. During the study, researchers will monitor clinical and laboratory indicators, record cardiovascular events, deaths, hospitalizations, and assess quality of life and treatment compliance over about one year. The primary outcomes include mortality rate, hospitalization rate, kidney disease quality of life, and incidence of cardiovascular events. The study aims to strengthen quality control in hemodialysis units and improve patient management and prognosis.
CONDITIONS
Brief Title
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with stage 5 chronic kidney disease who have received maintenance hemodialysis for more than 3 months
- Aged between 18 and 75 years old
- Receiving regular dialysis three times a week
- Have a relatively stable condition and can take care of themselves
- Willing to cooperate with the study
- Able to understand and proficiently use WeChat and the "Yueya" mini-program
You will not qualify if you...
- Patients with communication barriers or other conditions that prevent cooperation with the study
- History of acute myocardial infarction, cerebral infarction, or intracerebral hemorrhage in the past six months
- Not willing to actively cooperate with the study
- Severe liver cirrhosis, active tuberculosis, or AIDS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - About 1 year
Participants receive individualized daily life guidance through an APP for health education, diet, exercise, medication supervision, and condition monitoring, or continue routine management without the APP.
Regular outpatient visits during routine dialysis sessions
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016
Actively Recruiting
Research Team
Y
Yunfeng Xia Dr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here